(Q53250661)

12 May 2018

title

Long-term outcome results of the first tandem autotransplant trial for multiple myeloma. (English)

1 reference

12 May 2018

1 reference

1

Bart Barlogie

1 reference

12 May 2018

11

Antje Hoering

1 reference

12 May 2018

3

Frits van Rhee

1 reference

12 May 2018

author name string

Guido J Tricot

2

1 reference

12 May 2018

Edguardo Angtuaco

4

1 reference

12 May 2018

Ron Walker

5

1 reference

12 May 2018

Joshua Epstein

6

1 reference

12 May 2018

John D Shaughnessy

7

1 reference

12 May 2018

Sundar Jagannath

8

1 reference

12 May 2018

Vanessa Bolejack

9

1 reference

12 May 2018

Jennifer Gurley

10

1 reference

12 May 2018

David Vesole

12

1 reference

12 May 2018

Raman Desikan

13

1 reference

12 May 2018

David Siegel

14

1 reference

12 May 2018

Jayesh Mehta

15

1 reference

12 May 2018

Seema Singhal

16

1 reference

12 May 2018

Nikhil C Munshi

17

1 reference

12 May 2018

Madhav Dhodapkar

18

1 reference

12 May 2018

Bonnie Jenkins

19

1 reference

12 May 2018

Michel Attal

20

1 reference

12 May 2018

Jean-Luc Harousseau

21

1 reference

12 May 2018

John Crowley

22

1 reference

12 May 2018

language of work or name

English

0 references

publication date

25 August 2006

1 reference

12 May 2018

British Journal of Haematology

published in

1 reference

12 May 2018

volume

135

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

158-164

1 reference

12 May 2018

Single versus double autologous stem-cell transplantation for multiple myeloma.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06271.X

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06271.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06271.X

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06271.X

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06271.X

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06271.X

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06271.X

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06271.X

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06271.X

10.1111/J.1365-2141.2006.06271.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018